|
SLC35D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.674200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.252580E-01 |
| Normal-vs-Stage2 |
8.168200E-01 |
| Normal-vs-Stage3 |
9.757000E-01 |
| Normal-vs-Stage4 |
5.540800E-01 |
| Stage1-vs-Stage2 |
2.770000E-01 |
| Stage1-vs-Stage3 |
3.498400E-01 |
| Stage1-vs-Stage4 |
4.350000E-01 |
| Stage2-vs-Stage3 |
8.164000E-01 |
| Stage2-vs-Stage4 |
6.081600E-01 |
| Stage3-vs-Stage4 |
5.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.755000E-01 |
| Normal-vs-AfricanAmerican |
3.053800E-01 |
| Normal-vs-Asian |
8.398600E-01 |
| Caucasian-vs-AfricanAmerican |
5.572000E-01 |
| Caucasian-vs-Asian |
7.248000E-01 |
| AfricanAmerican-vs-Asian |
5.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.917000E-01 |
| Normal-vs-Female |
8.895200E-01 |
| Male-vs-Female |
5.016600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.519800E-01 |
| Normal-vs-Extreme_Weight |
6.427700E-02 |
| Normal-vs-Obese |
3.776200E-01 |
| Normal-vs-Extreme_Obese |
3.864600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.606800E-01 |
| Normal_Weight-vs-Obese |
7.850200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.038600E-01 |
| Extreme_Weight-vs-Obese |
3.992600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.526400E-01 |
| Obese-vs-Extreme_Obese |
7.034800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.574000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.243400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.530500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.055400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.619000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.143900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.165450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.236000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.659200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.094200E-01 |
| Normal-VS-Type2 PRCC |
1.457210E-01 |
| Normal-VS-KIRP CIMP |
1.758810E-01 |
| Normal-VS-Unclassified PRCC |
9.542400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.130400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.640840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.613000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.274840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.908000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.851170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.377600E-01 |
| Normal-vs-N1 |
7.027800E-01 |
| Normal-vs-N2 |
4.963000E-01 |
| N0-vs-N1 |
2.518200E-01 |
| N0-vs-N2 |
4.596400E-01 |
| N1-vs-N2 |
5.150400E-01 |
|
|
